Global /Australia /Healthcare /Biotechnology /NC6

Nanollose Ltd.

NC6

• ASX: NC6 • Delayed

0.0810AUD -1.2%

0.0571 USD

As of 16 June 2026, Nanollose Ltd. has a market cap of $20.19M USD, ranking #37043 globally and #1068 in Australia. It ranks #3324 in the Healthcare sector, and #649 in the Biotechnology industry.

Global Rank

37043

Country Rank

1068

Sector Rank

3324

Industry Rank

649

Key Stats

Market Cap

$20.19MUSD

28.54M AUD

Enterprise Value

$20.09MUSD

28.51M AUD

Revenue (TTM)

$167.09KUSD

236.19K AUD

EBITDA (TTM)

-$1.55MUSD

-2.21M AUD

Net Income (TTM)

-$1.58MUSD

-2.23M AUD

PS Ratio

120.8

PB Ratio

-168.1

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Biotechnology

CEO

Andrew Moullin open_in_new

Founded

2014

Website

nanollose.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	2.5%	30%	11%	58%	67%	78%	78%	-22%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	NC6 Nanollose Ltd ISIN: AU000000NC68 Shares Out.: Shares Outstanding: 408.954M¹ Shares Float: 302.065M² TV: TradingView: ASX: NC6 SA: Stock Analysis: ASX: NC6 YF: Yahoo Finance: NC6.AX GF: Google Finance: ASX: NC6 BA: Barron's: NC6 MS: Morningstar: XASX: NC6	0.0810 AUD	TV: TradingView: ASX: NC6 SA: Stock Analysis: ASX: NC6 YF: Yahoo Finance: NC6.AX GF: Google Finance: ASX: NC6 BA: Barron's: NC6 MS: Morningstar: XASX: NC6

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Nanollose Ltd.

Nanollose Limited, a biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia. The company offers Nullarbor Fibre, a tree-free Nullarbor lyocell fibre for use in textiles; Jelli Grow, an alternative seed germination and plant growing material; and Nufolium that is used for nonwoven applications, such as wipes. It also offers Biollose, a soilless growing media; and MicroGel, which is developed specifically for the commercial microgreens market. Nanollose Limited was incorporated in 2014 and is based in Nedlands, Australia.

Similar Companies

Industry: Biotechnology (Australia)

Name	Market Cap (USD) diff.	PE	Country
CSL Ltd. ASX: CSL	$42.64B 60.27B AUD 211K%	29.3	Australia
Telix Pharmaceuticals Ltd. ASX: TLX	$3.6B 5.09B AUD 18K%	-	Australia
Mesoblast Ltd. ASX: MSB	$2.04B 2.88B AUD 10K%	-	Australia
PolyNovo Ltd. ASX: PNV	$493.62M 697.75M AUD 2K%	71.8	Australia
Kazia Therapeutics Ltd. NASDAQ: KZIA	$141.64M 602%	-	Australia
Immutep Ltd. ASX: IMM	$65.68M 92.84M AUD 225%	-	Australia

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 903K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 792K%	19.0	United States
argenx SE EBR: ARGX	$47.99B 41.39B EUR 238K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$45.02B 68.19T KRW 223K%	35.5	South Korea
Lonza Group AG SIX: LONN	$42.46B 33.71B CHF 210K%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.23B 42.76T KRW 140K%	43.8	South Korea

chevron_leftBack